190 related articles for article (PubMed ID: 16457649)
1. Adenovirus-based cancer gene therapy.
Kaplan JM
Curr Gene Ther; 2005 Dec; 5(6):595-605. PubMed ID: 16457649
[TBL] [Abstract][Full Text] [Related]
2. Replicating adenoviruses in cancer therapy.
Dobbelstein M
Curr Top Microbiol Immunol; 2004; 273():291-334. PubMed ID: 14674605
[TBL] [Abstract][Full Text] [Related]
3. Selectively replicating adenoviruses for oncolytic therapy.
Yoon TK; Shichinohe T; Laquerre S; Kasahara N
Curr Cancer Drug Targets; 2001 Aug; 1(2):85-107. PubMed ID: 12188883
[TBL] [Abstract][Full Text] [Related]
4. Modifying adenoviral vectors for use as gene-based cancer vaccines.
Basak SK; Kiertscher SM; Harui A; Roth MD
Viral Immunol; 2004; 17(2):182-96. PubMed ID: 15279698
[TBL] [Abstract][Full Text] [Related]
5. Replication-selective oncolytic viruses in the treatment of cancer.
Everts B; van der Poel HG
Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
[TBL] [Abstract][Full Text] [Related]
6. Current advances and future challenges in Adenoviral vector biology and targeting.
Campos SK; Barry MA
Curr Gene Ther; 2007 Jun; 7(3):189-204. PubMed ID: 17584037
[TBL] [Abstract][Full Text] [Related]
7. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
8. Chapter eight--Oncolytic adenoviruses for cancer immunotherapy: data from mice, hamsters, and humans.
Cerullo V; Koski A; Vähä-Koskela M; Hemminki A
Adv Cancer Res; 2012; 115():265-318. PubMed ID: 23021247
[TBL] [Abstract][Full Text] [Related]
9. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
Dalba C; Klatzmann D; Logg CR; Kasahara N
Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
[TBL] [Abstract][Full Text] [Related]
10. Chapter six--Adenovirus-based immunotherapy of cancer: promises to keep.
de Gruijl TD; van de Ven R
Adv Cancer Res; 2012; 115():147-220. PubMed ID: 23021245
[TBL] [Abstract][Full Text] [Related]
11. Viral-mediated gene transfer for cancer treatment.
Wilson DR
Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
[TBL] [Abstract][Full Text] [Related]
12. Conditionally replicating adenoviruses for cancer treatment.
Jounaidi Y; Doloff JC; Waxman DJ
Curr Cancer Drug Targets; 2007 May; 7(3):285-301. PubMed ID: 17504125
[TBL] [Abstract][Full Text] [Related]
13. Engineering regulatory elements for conditionally-replicative adeno-viruses.
Haviv YS; Curiel DT
Curr Gene Ther; 2003 Aug; 3(4):357-85. PubMed ID: 12871022
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response.
Christ M; Lusky M; Stoeckel F; Dreyer D; Dieterlé A; Michou AI; Pavirani A; Mehtali M
Immunol Lett; 1997 Jun; 57(1-3):19-25. PubMed ID: 9232420
[TBL] [Abstract][Full Text] [Related]
15. Combining gene therapy and radiation against cancer.
Gridley DS; Slater JM
Curr Gene Ther; 2004 Sep; 4(3):231-48. PubMed ID: 15384938
[TBL] [Abstract][Full Text] [Related]
16. Advances in the techniques and methodologies of cancer gene therapy.
Sun W; Shi Q; Zhang H; Yang K; Ke Y; Wang Y; Qiao L
Discov Med; 2019 Jan; 27(146):45-55. PubMed ID: 30721651
[TBL] [Abstract][Full Text] [Related]
17. Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirus.
Hirvinen M; Rajecki M; Kapanen M; Parviainen S; Rouvinen-Lagerström N; Diaconu I; Nokisalmi P; Tenhunen M; Hemminki A; Cerullo V
Hum Gene Ther; 2015 Mar; 26(3):134-44. PubMed ID: 25557131
[TBL] [Abstract][Full Text] [Related]
18. Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.
Yoon AR; Hong J; Kim SW; Yun CO
Expert Opin Drug Deliv; 2016 Jun; 13(6):843-58. PubMed ID: 26967319
[TBL] [Abstract][Full Text] [Related]
19. Evolving gene therapy approaches for osteosarcoma using viral vectors: review.
Witlox MA; Lamfers ML; Wuisman PI; Curiel DT; Siegal GP
Bone; 2007 Apr; 40(4):797-812. PubMed ID: 17189720
[TBL] [Abstract][Full Text] [Related]
20. Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors.
Shayakhmetov DM; Li ZY; Ni S; Lieber A
J Immunol; 2005 Jun; 174(11):7310-9. PubMed ID: 15905578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
